Results 21 to 30 of about 117,301 (397)
BMC Psychiatry, 2017 BackgroundThe evidence on selective serotonin reuptake inhibitors (SSRIs) for major depressive disorder is unclear.MethodsOur objective was to conduct a systematic review assessing the effects of SSRIs versus placebo, ‘active’ placebo, or no intervention
J. Jakobsen +14 more
semanticscholar +1 more source
Serotonin reuptake inhibitors and cardiovascular disease [PDF]
, 2005 Selective serotonin re-uptake inhibiting drugs (SSRIs) are widely used for endogenous depression. In addition to depleting the nerve terminals of serotonin they also lower blood platelet serotonin levels.
Belcher, P.R. +2 more
core +1 more source
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. [PDF]
, 2011 BACKGROUND: Stroke is the major cause of adult disability. Selective serotonin reuptake inhibitors (SSRIs) have been used for many years to manage depression.
Anne Claxton +6 more
core +1 more source
Antidepressants in pregnancy and breastfeeding [PDF]
, 2007 Copyright © 2007 Australian Prescriber Reproduced with permission from Australian Prescriber The document attached has been archived with permission from the publisher/copyright holder.Maternal depression and anxiety during pregnancy and the early years ...
Sved-Williams, A.
core +1 more source
Serotonin Reuptake Inhibitor Increases Pseudarthrosis Rates in Anterior Cervical Discectomy and Fusions [PDF]
Asian Spine Journal, 2023 Study Design Retrospective cohort. Purpose To determine (1) the effects of serotonin reuptake inhibitors in pseudarthrosis rates after anterior cervical decompression and fusion (ACDF) and (2) to identify patient-reported outcome measures in patients ...
Mark James Lambrechts +15 more
doaj +1 more source
Oral selective serotonin reuptake inhibitors activate vagus nerve dependent gut-brain signalling
Scientific Reports, 2019 The vagus nerve can transmit signals to the brain resulting in a reduction in depressive behavior as evidenced by the long-term beneficial effects of electrical stimulation of the vagus in patients with intractable depression.
Karen‐Anne McVey Neufeld +9 more
semanticscholar +1 more source
Fluoxetine: a case history of its discovery and preclinical development [PDF]
, 2014 Introduction: Depression is a multifactorial mood disorder with a high prevalence worldwide. Until now, treatments for depression have focused on the inhibition of monoaminergic reuptake sites, which augment the bioavailability of monoamines in the CNS ...
Bel N +20 more
core +2 more sources
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
Selective Serotonin Reuptake Inhibitors for Stroke Recovery [PDF]
Stroke, 2020 Clinical Question Are selective serotonin reuptake inhibitors (SSRIs) associated with better recovery after stroke? Bottom Line SSRIs may be associated with improved recovery after stroke, even in persons without depression. However, much of the evidence is of poor quality.
Legg, Lynn A. +12 more
openaire +5 more sources
Female genital disorder as adverse symptom of lamotrigine treatment - A serotoninergic effect? [PDF]
, 1998 The new anticonvulsant, lamotrigine, is becoming an important tool in the treatment of bipolar disorder, including bipolar depression. Its efficacy in bipolar depression might be linked to its inhibition of serotonin uptake.
Amann, Benedikt +2 more
core +1 more source